SMART ANGEL 2: Evaluation of the Impact of the SMART ANGEL ™ Device on Follow-up at Home Following Major or Intermediate Outpatient Surgery

Sponsor
Centre Hospitalier Universitaire de Nīmes (Other)
Overall Status
Recruiting
CT.gov ID
NCT04068584
Collaborator
EVOLUCARE (Other)
1,260
24
3
29.9
52.5
1.8

Study Details

Study Description

Brief Summary

The investigators hypothesize that by monitoring and analyzing physiological parameters (heart rate, blood pressure, saturation) and well-being (pain, nausea, vomiting, comfort) the SMART ANGEL ™ device improves the quality of care after major or intermediate outpatient surgery. This active surveillance will result in a decrease in the rate of unplanned recourse (hospitalization, consultation, telephone call).

Condition or Disease Intervention/Treatment Phase
  • Other: Smart Angel
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1260 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Evaluation of the Impact of the SMART ANGEL ™ Device on Follow-up at Home Following Major or Intermediate Outpatient Surgery: Randomized Controlled Open-label Trial
Actual Study Start Date :
Feb 3, 2020
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Complete Smart Angel

Smat Angel application with artificial intelligence

Other: Smart Angel
Patient issued with a tablet with the Smart Angel application to monitor clinical signs and symptoms

Experimental: Basic Smart Angel

Smat Angel application without artificial intelligence

Other: Smart Angel
Patient issued with a tablet with the Smart Angel application to monitor clinical signs and symptoms

No Intervention: Control

Outcome Measures

Primary Outcome Measures

  1. Non-scheduled hospitalization rates between groups [Day 5]

  2. Number of non-scheduled consultations between groups [Day 5]

  3. Rates of calls with nurses between groups [Day 5]

  4. Rates of calls with doctors between groups [Day 5]

  5. Rates of unplanned prescriptions between groups [Day 5]

  6. Rates of unplanned exams between groups [Day 5]

Secondary Outcome Measures

  1. Rate of complications between groups [Day 1]

    % patients reported any of: nausea, vomiting, constipation, allergy, shivering, insomnia, pain, fever, sore throat, lower back pain, headache, hypotension, bradycardia, hallucination, fainting, reopening of the incision, repeated surgery, abscess, bleeding, or bruising

  2. Rate of complications between groups [Day 2]

    % patients reported any of: nausea, vomiting, constipation, allergy, shivering, insomnia, pain, fever, sore throat, lower back pain, headache, hypotension, bradycardia, hallucination, fainting, reopening of the incision, repeated surgery, abscess, bleeding, or bruising

  3. Rate of complications between groups [Day 3]

    % patients reported any of: nausea, vomiting, constipation, allergy, shivering, insomnia, pain, fever, sore throat, lower back pain, headache, hypotension, bradycardia, hallucination, fainting, reopening of the incision, repeated surgery, abscess, bleeding, or bruising

  4. Rate of complications between groups [Day 4]

    % patients reported any of: nausea, vomiting, constipation, allergy, shivering, insomnia, pain, fever, sore throat, lower back pain, headache, hypotension, bradycardia, hallucination, fainting, reopening of the incision, repeated surgery, abscess, bleeding, or bruising

  5. Rate of complications between groups [Day 5]

    % patients reported any of: nausea, vomiting, constipation, allergy, shivering, insomnia, pain, fever, sore throat, lower back pain, headache, hypotension, bradycardia, hallucination, fainting, reopening of the incision, repeated surgery, abscess, bleeding, or bruising

  6. Rate of complications between groups [Month 1]

    % patients reported any of: nausea, vomiting, constipation, allergy, shivering, insomnia, pain, fever, sore throat, lower back pain, headache, hypotension, bradycardia, hallucination, fainting, reopening of the incision, repeated surgery, abscess, bleeding, or bruising

  7. Rate of readmission between groups [Month 1]

    Yes/No

  8. Date of return to work or other activity [1 Month]

    Dd/mm/yyyy

  9. Patient satisfaction [Day 6]

    Visual Analog Scale 0-10

  10. Patient quality of life [1 month]

    EQ-5D-5L questionnaire taken over the phone

  11. Difficulties in using the device [Day 5]

    In-house developed usage questionnaire assessing measurement difficulties, saving errors, connection problems, problem contacting care staff

  12. Requirement of external help in using the device [Day 5]

    Description of person sought for advice

  13. Times spent on device [Day 5]

    Hours; automatically calculated by device for time used for manipulation and time for navigation

  14. Technical errors arising [Day 5]

    Automatically calculated by device

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • The patient must have given their free and informed consent and signed the consent form

  • The patient must be a member or beneficiary of a health insurance plan

  • The patient is undergoing ambulatory surgery for:

  • in orthopedics: shoulder (arthroscopy, abutment, prosthesis), hip (prosthesis, arthrolysis), knee (osteotomy, ligamentoplasty), ankle (prosthesis, ligamentoplasty) foot (hallux valgus); removal of major or multi-site equipment;

  • digestive (cholecystectomy, hernia repair, partial gastrectomy, colectomy, cleaning);

  • in gynecology (hysterectomy, oophorectomy, mastectomy, quadrantectomy, dissection, cystoplasty, sphincter);

  • in urology (total or partial resection of the prostate);

  • ENT (thyroidectomy, tonsillectomy);

  • Neurosurgery (herniated disc);

  • Vascular (stripping varix, creating fistula).

  • The patient has sufficient intellectual and cognitive capacity to use the devices

  • The patient must pass the test performed during the anesthesia consultation, namely:

  • open and connect the tablet,

  • activate the measurement of the blood pressure and the measurement of the oxygen saturation,

  • be connected to a 4G network

Exclusion Criteria:
  • The subject is in a period of exclusion determined by a previous study

  • The subject refuses to sign the consent

  • It is impossible to give the subject informed information

  • The patient is under safeguard of justice or state guardianship

  • The patient is pregnant

  • The patient is undergoing emergency or minor surgery

  • Patient has a psychological class ASA 5

  • Patient is non-eligible for ambulatory surgery for medical reasons (decompensated medical pathology) or social reasons according to the criteria defined by the société française anesthésie réanimation. Person lives alone or has a geographical distance from a hospital center> 30 km (or> 45 min by car).

  • Patient who doesn't classify for ambulatory surgery at time of discharge

Contacts and Locations

Locations

Site City State Country Postal Code
1 Polyclinique du Parc Rambot Aix-en-Provence France 13100
2 Clinique Bonnefon Alès France 30100
3 Centre hospitalier universitaire Amiens-Picardie Amiens France 80054
4 Centre hospitalier D'Arles Arles France 13637
5 Centre Hospitalier Henri Duffaut Avignon France 84000
6 CHU Bordeaux II Bordeaux France 33000
7 CH antoine gayraud Carcassonne France
8 Hôpital Henri-Mondor Créteil France 94010
9 CHU Lille Lille France 59000
10 Clinique Via Domitia Lunel France 34400
11 Lyon Sud Lyon France
12 Hopital Nord Marseille France 13915
13 ICM Montpellier France 34000
14 Hopital Saint Eloi Montpellier France 34090
15 Hôpital Lapeyronie Montpellier France 34090
16 Clinique des Franciscaines Nimes France 30032
17 CHU de Nimes Nîmes France 30029
18 Clinique Kenval Nîmes France 30900
19 Polyclinique Grand Sud Nîmes France 30900
20 Clinique Jouvenet Paris France 75016
21 Hôpital Universitaire Pitié Salpêtrière Paris France 75651
22 Institut Mutualiste Montsouris Paris France 75674
23 CHU de Rennes Rennes France 35033
24 CHU de Saint-Etienne Saint-Étienne France 42055

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Nīmes
  • EVOLUCARE

Investigators

  • Study Director: Christhophe Boisson, CHU Nimes

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Nīmes
ClinicalTrials.gov Identifier:
NCT04068584
Other Study ID Numbers:
  • CIVI/2018/PC-01
First Posted:
Aug 28, 2019
Last Update Posted:
Aug 5, 2021
Last Verified:
Aug 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Aug 5, 2021